Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 259

1.

Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States.

Feldman SR, Rastogi S, Lin J.

Dermatol Ther (Heidelb). 2018 Jul 13. doi: 10.1007/s13555-018-0251-4. [Epub ahead of print]

PMID:
30006866
2.

Patient Reported Improvement After Patch Testing and Allergen Avoidance Counseling: A Retrospective Analysis.

Steuer MS, Botto NC.

Dermatol Ther (Heidelb). 2018 Jul 9. doi: 10.1007/s13555-018-0250-5. [Epub ahead of print]

PMID:
29987683
3.

Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations.

Ebbelaar CCF, Venema AW, Van Dijk MR.

Dermatol Ther (Heidelb). 2018 Jun 25. doi: 10.1007/s13555-018-0249-y. [Epub ahead of print] Review.

PMID:
29943217
4.

Efficacy Endpoints in Clinical Trials in Actinic Keratosis.

Skov T, Stockfleth E, Szeimies RM, Berman B.

Dermatol Ther (Heidelb). 2018 Jun 18. doi: 10.1007/s13555-018-0247-0. [Epub ahead of print]

PMID:
29916197
5.

Development of Low-Cost Locally Sourced Two-Component Compression Bandages in Western Kenya.

Chang AY, Tonui EC, Momanyi D, Mills AR, Wasike P, Karwa R, Maurer TA, Pastakia SD.

Dermatol Ther (Heidelb). 2018 Jun 15. doi: 10.1007/s13555-018-0248-z. [Epub ahead of print]

PMID:
29905913
6.

Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts.

Sanchez IM, Shankle L, Wan MT, Afifi L, Wu JJ, Doris F, Bridges A, Boas M, Lafoy B, Truman S, Orbai AM, Takeshita J, Gelfand JM, Armstrong AW, Siegel MP, Liao W.

Dermatol Ther (Heidelb). 2018 Jun 6. doi: 10.1007/s13555-018-0242-5. [Epub ahead of print]

PMID:
29876724
7.

Basal Cell Carcinoma: A Patient and Physician's Experience.

Cohen BJ, Cohen ES, Cohen PR.

Dermatol Ther (Heidelb). 2018 Jun 2. doi: 10.1007/s13555-018-0245-2. [Epub ahead of print]

PMID:
29860652
8.

A Systematic Scoping Literature Review of Publications Supporting Treatment Guidelines for Pediatric Atopic Dermatitis in Contrast to Clinical Practice Patterns.

Siegfried EC, Jaworski JC, Mina-Osorio P.

Dermatol Ther (Heidelb). 2018 Jun 1. doi: 10.1007/s13555-018-0243-4. [Epub ahead of print] Review.

PMID:
29858763
9.
10.

Squamous Cell Carcinomas in Two Cases of Nail Lichen Planus: Is There a Real Association?

Costa C, Villani A, Russo D, Cappello M, De Fata Salvatores G, Scalvenzi M.

Dermatol Ther (Heidelb). 2018 May 31. doi: 10.1007/s13555-018-0246-1. [Epub ahead of print]

PMID:
29855895
11.

Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders.

Pigatto PD, Diani M.

Dermatol Ther (Heidelb). 2018 May 22. doi: 10.1007/s13555-018-0239-0. [Epub ahead of print] Review.

PMID:
29790104
12.

Integra®-Dermal Regeneration Template and Split-Thickness Skin Grafting: A Therapy Approach to Correct Aplasia Cutis Congenita and Epidermolysis Bullosa in Carmi Syndrome.

Trah J, Has C, Hausser I, Kutzner H, Reinshagen K, Königs I.

Dermatol Ther (Heidelb). 2018 Jun;8(2):313-321. doi: 10.1007/s13555-018-0237-2. Epub 2018 May 18.

13.

Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.

Mandel VD, Guanti MB, Liberati S, Demonte A, Pellacani G, Pepe P.

Dermatol Ther (Heidelb). 2018 May 16. doi: 10.1007/s13555-018-0240-7. [Epub ahead of print]

14.

Exploration of Patient Characteristics and Quality of Life in Patients with Lipoedema Using a Survey.

Romeijn JRM, de Rooij MJM, Janssen L, Martens H.

Dermatol Ther (Heidelb). 2018 Jun;8(2):303-311. doi: 10.1007/s13555-018-0241-6. Epub 2018 May 10.

15.

Effect of Topical Steroids on Skin Prick Test: A Randomized Controlled Trial.

Ebbesen AR, Riis LA, Gradman J.

Dermatol Ther (Heidelb). 2018 Jun;8(2):285-290. doi: 10.1007/s13555-018-0238-1. Epub 2018 May 4.

16.

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis.

Watanabe D, Mizukami A, Holl K, Curran D, Van Oorschot D, Varghese L, Shiragami M.

Dermatol Ther (Heidelb). 2018 Jun;8(2):269-284. doi: 10.1007/s13555-018-0236-3. Epub 2018 Apr 21.

17.

A Scoping Review Protocol to Explore the Use of Interleukin-1-Targeting Drugs for the Treatment of Dermatological Diseases: Indications, Mechanism of Action, Efficacy, and Safety.

Gómez-García F, Ruano J, Gay-Mimbrera J, Aguilar-Luque M, Sanz-Cabanillas JL, Hernández Romero JL, Garcia-Nieto AV.

Dermatol Ther (Heidelb). 2018 Jun;8(2):195-202. doi: 10.1007/s13555-018-0235-4. Epub 2018 Apr 6. Review.

18.

Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride.

Sorbellini E, Pinto D, Marzani B, Rinaldi F.

Dermatol Ther (Heidelb). 2018 Jun;8(2):259-267. doi: 10.1007/s13555-018-0233-6. Epub 2018 Mar 24.

19.

Author Correction: Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab.

Spindeldreher S, Maillère B, Correia E, Tenon M, Karle A, Jarvis P, Kolbinger F.

Dermatol Ther (Heidelb). 2018 Jun;8(2):327. doi: 10.1007/s13555-018-0234-5.

20.

Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars.

Loss MJ, Leung S, Chien A, Kerrouche N, Fischer AH, Kang S.

Dermatol Ther (Heidelb). 2018 Jun;8(2):245-257. doi: 10.1007/s13555-018-0231-8. Epub 2018 Mar 16.

Supplemental Content

Loading ...
Support Center